Private Trust CO Na Eli Lilly & CO Transaction History

Private Trust CO Na

$1.07 Billion
Q3 2025

A detailed history of Private Trust CO Na transactions in Eli Lilly & CO stock. As of the latest transaction made, Private Trust CO Na holds 9,531 shares of LLY stock, worth $8.22 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

9,531

Previous 11,979 20.44%

Holding current value

$8.22 Million

Previous $9.34 Million 22.12%

% of portfolio

0.68%

Previous 0.94%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$625.65 - $812.69 $1.53 Million - $1.99 Million	-2,448 Reduced 20.44%	9,531 $7.27 Million
Q2 2025 Jul 29, 2025	BUY	$713.71 - $898.95 $375,411 - $472,847	526 Added 4.59%	11,979 $9.34 Million
Q1 2025 Apr 28, 2025	BUY	$725.72 - $929.72 $16,691 - $21,383	23 Added 0.2%	11,453 $9.46 Million
Q4 2024 Feb 05, 2025	SELL	$727.2 - $932.06 $624,664 - $800,639	-859 Reduced 6.99%	11,430 $8.82 Million
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $161,377 - $200,644	209 Added 1.73%	12,289 $10.9 Million
Q2 2024 Jul 23, 2024	BUY	$724.87 - $909.04 $669,055 - $839,043	923 Added 8.27%	12,080 $10.9 Million
Q1 2024 Apr 24, 2024	SELL	$592.2 - $792.28 $7,106 - $9,507	-12 Reduced 0.11%	11,157 $8.68 Million
Q4 2023 Jan 24, 2024	BUY	$525.19 - $619.13 $438,008 - $516,354	834 Added 8.07%	11,169 $6.51 Million
Q3 2023 Oct 18, 2023	BUY	$434.7 - $599.3 $27,820 - $38,355	64 Added 0.62%	10,335 $5.55 Million
Q2 2023 Jul 28, 2023	BUY	$350.74 - $468.98 $1,402 - $1,875	4 Added 0.04%	10,271 $4.82 Million
Q1 2023 Apr 12, 2023	BUY	$310.63 - $364.82 $211,849 - $248,807	682 Added 7.12%	10,267 $3.53 Million
Q4 2022 Jan 18, 2023	BUY	$321.55 - $374.67 $99,680 - $116,147	310 Added 3.34%	9,585 $0
Q3 2022 Oct 17, 2022	SELL	$296.48 - $337.87 $291,143 - $331,788	-982 Reduced 9.57%	9,275 $3 Million
Q2 2022 Sep 16, 2022	BUY	$278.73 - $327.27 $114,279 - $134,180	410 Added 4.16%	10,257 $3.33 Million
Q1 2022 Apr 12, 2022	SELL	$234.69 - $291.66 $68,294 - $84,873	-291 Reduced 2.87%	9,847 $2.82 Million
Q4 2021 Jan 10, 2022	SELL	$224.85 - $279.04 $20,686 - $25,671	-92 Reduced 0.9%	10,138 $2.8 Million
Q3 2021 Oct 06, 2021	SELL	$221.6 - $272.71 $31,910 - $39,270	-144 Reduced 1.39%	10,230 $2.36 Million
Q2 2021 Jul 07, 2021	BUY	$180.55 - $233.54 $9,569 - $12,377	53 Added 0.51%	10,374 $2.38 Million
Q1 2021 Apr 06, 2021	BUY	$164.32 - $212.72 $251,409 - $325,461	1,530 Added 17.4%	10,321 $1.93 Million
Q4 2020 Jan 05, 2021	BUY	$130.46 - $172.63 $204,039 - $269,993	1,564 Added 21.64%	8,791 $1.48 Million
Q3 2020 Oct 01, 2020	BUY	$146.22 - $169.13 $48,691 - $56,320	333 Added 4.83%	7,227 $1.07 Million
Q2 2020 Jul 07, 2020	BUY	$136.42 - $164.18 $312,128 - $375,643	2,288 Added 49.67%	6,894 $1.13 Million
Q1 2020 Apr 07, 2020	SELL	$119.05 - $147.35 $94,049 - $116,406	-790 Reduced 14.64%	4,606 $638,000
Q4 2019 Jan 02, 2020	BUY	$106.92 - $132.43 $25,767 - $31,915	241 Added 4.68%	5,396 $709,000
Q3 2019 Oct 01, 2019	SELL	$106.79 - $116.16 $123,769 - $134,629	-1,159 Reduced 18.36%	5,155 $576,000
Q2 2019 Jul 02, 2019	BUY	$110.79 - $129.32 $25,814 - $30,131	233 Added 3.83%	6,314 $0
Q1 2019 Apr 02, 2019	BUY	$111.31 - $131.02 $12,800 - $15,067	115 Added 1.93%	6,081 $0
Q4 2018 Jan 03, 2019	BUY	$105.9 - $118.64 $6,459 - $7,237	61 Added 1.03%	5,966 $690,000
Q3 2018 Oct 09, 2018	SELL	$85.86 - $107.31 $252,514 - $315,598	-2,941 Reduced 33.25%	5,905 $0
Q2 2018 Jul 03, 2018	SELL	$75.7 - $86.88 $1,968 - $2,258	-26 Reduced 0.29%	8,846 $0
Q1 2018 Apr 03, 2018	BUY	$74.21 - $87.6 $7,866 - $9,285	106 Added 1.21%	8,872 $0
Q4 2017 Jan 16, 2018	BUY	$81.94 - $87.89 $39,986 - $42,890	488 Added 5.9%	8,766 $0
Q3 2017 Oct 12, 2017	BUY	$77.07 - $85.54 $637,985 - $708,100	8,278	8,278 $0

Others Institutions Holding LLY

# of Institutions

4,470

Shares Held

779M

Call Options Held

16.9M

Put Options Held

12.6M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $820B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.

Account

Private Trust CO Na Eli Lilly & CO Transaction History